Ultimovacs Competitors and Similar CompaniesClear all
Ultimovacs's competitors and similar companies include Pharmacyclics.
 Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1991 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations Oslo, NO HQ Uppsala, SE | Locations Sunnyvale, US HQ |
Employees | Employees 19 | Employees 6551% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit N/A | Gross profit $689.3m (FY, 2014) |
Net income | Net income (kr140.7m) (FY, 2025) | Net income $86.1m (FY, 2014) |
For sources of this data, please see the company profile
View Company Profiles
Pharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company